Paloma Partners’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-65,585
| Closed | -$395K | – | 2395 |
|
|
2019
Q4 | $395K | Buy |
65,585
+52,785
| +412% | +$306K | 0.01% | 1564 |
|
|
2019
Q3 | $46K | Sell |
12,800
-14,630
| -53% | -$56.4K | ﹤0.01% | 1881 |
|
|
2019
Q2 | $74K | Buy |
+27,430
| New | +$81K | ﹤0.01% | 1646 |
|
|
2018
Q4 | – | Sell |
-26,400
| Closed | -$97K | – | 1949 |
|
|
2018
Q3 | $97K | Buy |
+26,400
| New | +$78.7K | ﹤0.01% | 1453 |
|
|
2018
Q1 | – | Sell |
-13,865
| Closed | -$40K | – | 2393 |
|
|
2017
Q4 | $40K | Buy |
+13,865
| New | +$50.4K | ﹤0.01% | 1825 |
|
|
2017
Q3 | – | Sell |
-13,200
| Closed | -$61K | – | 2611 |
|
|
2017
Q2 | $61K | Buy |
+13,200
| New | +$53.1K | ﹤0.01% | 2104 |
|
|
2015
Q2 | – | Sell |
-33,051
| Closed | -$326K | – | 2011 |
|
|
2015
Q1 | $326K | Buy |
+33,051
| New | +$413K | 0.01% | 929 |
|